AI can be a personal trainer in your pocket – but is it safe? 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings 
Samsung, SK Hynix to Unveil $1.3 Trillion AI and Semiconductor Investment Plan 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox 
Anthropic Brings Claude AI Models to Microsoft Azure Foundry With NVIDIA Blackwell GPUs 
Morgan Stanley Raises Tesla Q2 Delivery Forecast on Strong Europe and China Demand 
SoftBank Shares Slide as OpenAI IPO Delay Concerns Weigh on AI Investment Outlook 
Australia Sues Amazon Over Prime Video Ads and Subscription Terms 
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service 
Nvidia Stock Rises as SemiAnalysis Sees AI Data Center Revenue Beating Wall Street Forecasts 
Apple Supplier Stocks Slide as Samsung, SK Hynix Lead Selloff After Apple Price Hikes 
Firmus Partners With Nvidia to Deliver 170,000 AI GPUs in $30 Billion Cloud Infrastructure Deal 
Apple Challenges India Antitrust Probe, Says CCI Copied Rivals’ Claims in App Store Case 
Chip Stocks Rally as Samsung and SK Hynix’s $1.3 Trillion Investment Plan Boosts AI Optimism 
Anthropic Restores Claude Fable 5 and Mythos 5 After U.S. Lifts AI Export Controls 
Elon Musk's neurotech business Neuralink implanted its gadget in a person for the first time on Sunday, and the patient is "recovering well," the billionaire said on X, formerly known as Twitter, on Monday.
Elon Musk's Neuralink Implants Brain Technology in Human Patients for the First Time
The business is creating a brain implant that will allow people with severe paralysis to operate external technology using just neural inputs. As per CNBC, Neuralink began enrolling patients for its first-in-human clinical study in the autumn after permission from the United States.
As per a blog post, the Food and Drug Administration planned to undertake the research in May. According to an X post, Musk announced on Monday that Neuralink's first product will be named Telepathy.
If the technology works successfully, individuals with severe degenerative diseases such as ALS might one day utilize the implant to communicate or access social media by manipulating cursors and typing with their brains.
Musk wrote, "Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal. "
The in-human clinical study is just one step on Neuralink's journey to commercialization. Medical device businesses must undergo multiple stages of rigorous data safety collection and testing before receiving ultimate FDA clearance. Neuralink does not specify how many human patients will participate in its first-in-human experiment.
Exploring the Frontier: Neuralink Leads in the Brain-Computer Interface Revolution
Neuralink, as part of the burgeoning brain-computer interface, or BCI, business, is likely the best-known firm in the area due to Musk's high profile as CEO of Tesla and SpaceX. A BCI is a device that deciphers brain impulses and converts them into commands for external technology. Numerous businesses, including Synchron, Precision Neuroscience, Paradromics, and Blackrock Neurotech, have developed systems with similar capabilities.
Paradromics plans to begin its first trial with human patients in the first part of this year. Precision Neuroscience completed its first-in-human clinical research last year. In 2021, a patient who got Synchron's BCI utilized it to tweet from CEO Tom Oxley's Twitter account.
